nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—ABCB1—peripheral nervous system neoplasm	0.283	1	CbGaD
Doxepin—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0341	0.113	CbGbCtD
Doxepin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0298	0.0989	CbGbCtD
Doxepin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0298	0.0989	CbGbCtD
Doxepin—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0285	0.0948	CbGbCtD
Doxepin—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0272	0.0905	CbGbCtD
Doxepin—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0207	0.0686	CbGbCtD
Doxepin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0179	0.0593	CbGbCtD
Doxepin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0166	0.0551	CbGbCtD
Doxepin—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0133	0.0443	CbGbCtD
Doxepin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0127	0.0422	CbGbCtD
Doxepin—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0122	0.0406	CbGbCtD
Doxepin—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0119	0.0394	CbGbCtD
Doxepin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0117	0.0387	CbGbCtD
Doxepin—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00795	0.0264	CbGbCtD
Doxepin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00762	0.0253	CbGbCtD
Doxepin—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00749	0.0249	CbGbCtD
Doxepin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00698	0.0232	CbGbCtD
Doxepin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00476	0.0158	CbGbCtD
Doxepin—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.0044	0.163	CbGeAlD
Doxepin—HTR6—ganglion—peripheral nervous system neoplasm	0.002	0.0741	CbGeAlD
Doxepin—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00161	0.0595	CbGeAlD
Doxepin—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.0015	0.0557	CbGeAlD
Doxepin—Amitriptyline—NTRK2—peripheral nervous system neoplasm	0.00144	0.42	CrCbGaD
Doxepin—HTR2C—ganglion—peripheral nervous system neoplasm	0.00116	0.0428	CbGeAlD
Doxepin—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00115	0.0424	CbGeAlD
Doxepin—HTR2A—pons—peripheral nervous system neoplasm	0.00113	0.0419	CbGeAlD
Doxepin—SLC6A4—ganglion—peripheral nervous system neoplasm	0.0011	0.0406	CbGeAlD
Doxepin—SLC6A2—nerve—peripheral nervous system neoplasm	0.000978	0.0362	CbGeAlD
Doxepin—HTR1A—ganglion—peripheral nervous system neoplasm	0.000974	0.036	CbGeAlD
Doxepin—SLC6A2—ganglion—peripheral nervous system neoplasm	0.000965	0.0357	CbGeAlD
Doxepin—Amitriptyline—NTRK1—peripheral nervous system neoplasm	0.000892	0.26	CrCbGaD
Doxepin—DRD2—nerve—peripheral nervous system neoplasm	0.000891	0.033	CbGeAlD
Doxepin—DRD2—ganglion—peripheral nervous system neoplasm	0.00088	0.0326	CbGeAlD
Doxepin—HTR2A—nerve—peripheral nervous system neoplasm	0.000588	0.0217	CbGeAlD
Doxepin—HTR2A—ganglion—peripheral nervous system neoplasm	0.00058	0.0215	CbGeAlD
Doxepin—CHRM1—parotid gland—peripheral nervous system neoplasm	0.000506	0.0187	CbGeAlD
Doxepin—HTR2C—brainstem—peripheral nervous system neoplasm	0.000503	0.0186	CbGeAlD
Doxepin—SLC6A4—brainstem—peripheral nervous system neoplasm	0.000477	0.0176	CbGeAlD
Doxepin—KCNH2—trigeminal ganglion—peripheral nervous system neoplasm	0.000426	0.0158	CbGeAlD
Doxepin—HTR1A—brainstem—peripheral nervous system neoplasm	0.000423	0.0157	CbGeAlD
Doxepin—ADRA2C—trigeminal ganglion—peripheral nervous system neoplasm	0.00042	0.0155	CbGeAlD
Doxepin—SLC6A2—brainstem—peripheral nervous system neoplasm	0.00042	0.0155	CbGeAlD
Doxepin—ADRA2C—parotid gland—peripheral nervous system neoplasm	0.000396	0.0147	CbGeAlD
Doxepin—ADRA1A—brainstem—peripheral nervous system neoplasm	0.00039	0.0144	CbGeAlD
Doxepin—DRD2—brainstem—peripheral nervous system neoplasm	0.000382	0.0142	CbGeAlD
Doxepin—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.000341	0.0126	CbGeAlD
Doxepin—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000335	0.0124	CbGeAlD
Doxepin—HTR2A—brainstem—peripheral nervous system neoplasm	0.000252	0.00933	CbGeAlD
Doxepin—CYP2D6—brainstem—peripheral nervous system neoplasm	0.00023	0.0085	CbGeAlD
Doxepin—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000209	0.00772	CbGeAlD
Doxepin—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.000192	0.00712	CbGeAlD
Doxepin—DRD2—cerebellum—peripheral nervous system neoplasm	0.000189	0.00698	CbGeAlD
Doxepin—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000187	0.00691	CbGeAlD
Doxepin—KCNH2—cerebellum—peripheral nervous system neoplasm	0.000186	0.00688	CbGeAlD
Doxepin—Clomipramine—ABCB1—peripheral nervous system neoplasm	0.000184	0.0536	CrCbGaD
Doxepin—Chlorprothixene—ABCB1—peripheral nervous system neoplasm	0.000184	0.0534	CrCbGaD
Doxepin—ADRA2C—cerebellum—peripheral nervous system neoplasm	0.000183	0.00678	CbGeAlD
Doxepin—Trimipramine—ABCB1—peripheral nervous system neoplasm	0.00017	0.0494	CrCbGaD
Doxepin—Promethazine—ABCB1—peripheral nervous system neoplasm	0.000163	0.0475	CrCbGaD
Doxepin—Desipramine—ABCB1—peripheral nervous system neoplasm	0.000148	0.0432	CrCbGaD
Doxepin—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.000146	0.00541	CbGeAlD
Doxepin—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000422	CcSEcCtD
Doxepin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000131	0.000421	CcSEcCtD
Doxepin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000131	0.00042	CcSEcCtD
Doxepin—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000419	CcSEcCtD
Doxepin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00013	0.000417	CcSEcCtD
Doxepin—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00013	0.000416	CcSEcCtD
Doxepin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000129	0.000414	CcSEcCtD
Doxepin—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000413	CcSEcCtD
Doxepin—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000411	CcSEcCtD
Doxepin—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000411	CcSEcCtD
Doxepin—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000411	CcSEcCtD
Doxepin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000128	0.000411	CcSEcCtD
Doxepin—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.00041	CcSEcCtD
Doxepin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000128	0.00041	CcSEcCtD
Doxepin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000127	0.000407	CcSEcCtD
Doxepin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000127	0.000406	CcSEcCtD
Doxepin—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000405	CcSEcCtD
Doxepin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000126	0.000404	CcSEcCtD
Doxepin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000126	0.000403	CcSEcCtD
Doxepin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000126	0.000403	CcSEcCtD
Doxepin—Imipramine—ABCB1—peripheral nervous system neoplasm	0.000126	0.0366	CrCbGaD
Doxepin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000403	CcSEcCtD
Doxepin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000401	CcSEcCtD
Doxepin—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000401	CcSEcCtD
Doxepin—Amitriptyline—ABCB1—peripheral nervous system neoplasm	0.000125	0.0364	CrCbGaD
Doxepin—Pain—Etoposide—peripheral nervous system neoplasm	0.000125	0.0004	CcSEcCtD
Doxepin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000125	0.0004	CcSEcCtD
Doxepin—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000399	CcSEcCtD
Doxepin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000399	CcSEcCtD
Doxepin—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000124	0.0046	CbGeAlD
Doxepin—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000396	CcSEcCtD
Doxepin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000124	0.000396	CcSEcCtD
Doxepin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000123	0.000395	CcSEcCtD
Doxepin—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000394	CcSEcCtD
Doxepin—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000394	CcSEcCtD
Doxepin—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000389	CcSEcCtD
Doxepin—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000388	CcSEcCtD
Doxepin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000386	CcSEcCtD
Doxepin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00012	0.000385	CcSEcCtD
Doxepin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00012	0.000384	CcSEcCtD
Doxepin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000383	CcSEcCtD
Doxepin—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000382	CcSEcCtD
Doxepin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000119	0.000382	CcSEcCtD
Doxepin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000119	0.000382	CcSEcCtD
Doxepin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000119	0.000381	CcSEcCtD
Doxepin—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00038	CcSEcCtD
Doxepin—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00038	CcSEcCtD
Doxepin—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00038	CcSEcCtD
Doxepin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000118	0.000378	CcSEcCtD
Doxepin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000118	0.000377	CcSEcCtD
Doxepin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000117	0.000376	CcSEcCtD
Doxepin—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000376	CcSEcCtD
Doxepin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000117	0.000375	CcSEcCtD
Doxepin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000373	CcSEcCtD
Doxepin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000116	0.000371	CcSEcCtD
Doxepin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000371	CcSEcCtD
Doxepin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000371	CcSEcCtD
Doxepin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000115	0.00037	CcSEcCtD
Doxepin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000115	0.00037	CcSEcCtD
Doxepin—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.00037	CcSEcCtD
Doxepin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000369	CcSEcCtD
Doxepin—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000367	CcSEcCtD
Doxepin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000115	0.000367	CcSEcCtD
Doxepin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000114	0.000366	CcSEcCtD
Doxepin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000366	CcSEcCtD
Doxepin—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000365	CcSEcCtD
Doxepin—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000364	CcSEcCtD
Doxepin—Rash—Vincristine—peripheral nervous system neoplasm	0.000114	0.000364	CcSEcCtD
Doxepin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000114	0.000364	CcSEcCtD
Doxepin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000363	CcSEcCtD
Doxepin—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000113	0.00419	CbGeAlD
Doxepin—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000362	CcSEcCtD
Doxepin—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000362	CcSEcCtD
Doxepin—Headache—Vincristine—peripheral nervous system neoplasm	0.000113	0.000362	CcSEcCtD
Doxepin—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.00036	CcSEcCtD
Doxepin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000357	CcSEcCtD
Doxepin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000111	0.000356	CcSEcCtD
Doxepin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000355	CcSEcCtD
Doxepin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000109	0.000349	CcSEcCtD
Doxepin—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000347	CcSEcCtD
Doxepin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000345	CcSEcCtD
Doxepin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000108	0.000344	CcSEcCtD
Doxepin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000344	CcSEcCtD
Doxepin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000107	0.000343	CcSEcCtD
Doxepin—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000342	CcSEcCtD
Doxepin—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000342	CcSEcCtD
Doxepin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000341	CcSEcCtD
Doxepin—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.00034	CcSEcCtD
Doxepin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000339	CcSEcCtD
Doxepin—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000337	CcSEcCtD
Doxepin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000336	CcSEcCtD
Doxepin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000105	0.000335	CcSEcCtD
Doxepin—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000335	CcSEcCtD
Doxepin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000335	CcSEcCtD
Doxepin—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000335	CcSEcCtD
Doxepin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000333	CcSEcCtD
Doxepin—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000332	CcSEcCtD
Doxepin—Chills—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000331	CcSEcCtD
Doxepin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000103	0.000331	CcSEcCtD
Doxepin—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000103	0.00033	CcSEcCtD
Doxepin—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000326	CcSEcCtD
Doxepin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000101	0.000324	CcSEcCtD
Doxepin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000323	CcSEcCtD
Doxepin—Rash—Cisplatin—peripheral nervous system neoplasm	0.0001	0.000322	CcSEcCtD
Doxepin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.0001	0.000321	CcSEcCtD
Doxepin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000321	CcSEcCtD
Doxepin—Erythema—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000321	CcSEcCtD
Doxepin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	9.99e-05	0.00032	CcSEcCtD
Doxepin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	9.96e-05	0.000319	CcSEcCtD
Doxepin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	9.94e-05	0.000318	CcSEcCtD
Doxepin—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	9.89e-05	0.000317	CcSEcCtD
Doxepin—Flushing—Doxorubicin—peripheral nervous system neoplasm	9.89e-05	0.000317	CcSEcCtD
Doxepin—Flatulence—Epirubicin—peripheral nervous system neoplasm	9.88e-05	0.000316	CcSEcCtD
Doxepin—Tension—Epirubicin—peripheral nervous system neoplasm	9.84e-05	0.000315	CcSEcCtD
Doxepin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	9.82e-05	0.000314	CcSEcCtD
Doxepin—Nervousness—Epirubicin—peripheral nervous system neoplasm	9.74e-05	0.000312	CcSEcCtD
Doxepin—Back pain—Epirubicin—peripheral nervous system neoplasm	9.7e-05	0.000311	CcSEcCtD
Doxepin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	9.67e-05	0.00031	CcSEcCtD
Doxepin—Dizziness—Etoposide—peripheral nervous system neoplasm	9.65e-05	0.000309	CcSEcCtD
Doxepin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	9.64e-05	0.000309	CcSEcCtD
Doxepin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	9.63e-05	0.000308	CcSEcCtD
Doxepin—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	9.61e-05	0.000308	CcSEcCtD
Doxepin—Chills—Doxorubicin—peripheral nervous system neoplasm	9.56e-05	0.000306	CcSEcCtD
Doxepin—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	9.52e-05	0.000305	CcSEcCtD
Doxepin—Nausea—Cisplatin—peripheral nervous system neoplasm	9.47e-05	0.000303	CcSEcCtD
Doxepin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	9.45e-05	0.000303	CcSEcCtD
Doxepin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	9.42e-05	0.000302	CcSEcCtD
Doxepin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	9.34e-05	0.000299	CcSEcCtD
Doxepin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	9.3e-05	0.000298	CcSEcCtD
Doxepin—Vomiting—Etoposide—peripheral nervous system neoplasm	9.28e-05	0.000297	CcSEcCtD
Doxepin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	9.28e-05	0.000297	CcSEcCtD
Doxepin—Erythema—Doxorubicin—peripheral nervous system neoplasm	9.28e-05	0.000297	CcSEcCtD
Doxepin—Anaemia—Epirubicin—peripheral nervous system neoplasm	9.27e-05	0.000297	CcSEcCtD
Doxepin—Agitation—Epirubicin—peripheral nervous system neoplasm	9.21e-05	0.000295	CcSEcCtD
Doxepin—Rash—Etoposide—peripheral nervous system neoplasm	9.2e-05	0.000295	CcSEcCtD
Doxepin—Dermatitis—Etoposide—peripheral nervous system neoplasm	9.2e-05	0.000295	CcSEcCtD
Doxepin—Headache—Etoposide—peripheral nervous system neoplasm	9.15e-05	0.000293	CcSEcCtD
Doxepin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	9.14e-05	0.000293	CcSEcCtD
Doxepin—Tension—Doxorubicin—peripheral nervous system neoplasm	9.1e-05	0.000292	CcSEcCtD
Doxepin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	9.09e-05	0.000291	CcSEcCtD
Doxepin—Malaise—Epirubicin—peripheral nervous system neoplasm	9.04e-05	0.00029	CcSEcCtD
Doxepin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	9.01e-05	0.000289	CcSEcCtD
Doxepin—Vertigo—Epirubicin—peripheral nervous system neoplasm	9.01e-05	0.000289	CcSEcCtD
Doxepin—Syncope—Epirubicin—peripheral nervous system neoplasm	8.99e-05	0.000288	CcSEcCtD
Doxepin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	8.98e-05	0.000287	CcSEcCtD
Doxepin—Back pain—Doxorubicin—peripheral nervous system neoplasm	8.97e-05	0.000287	CcSEcCtD
Doxepin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	8.92e-05	0.000286	CcSEcCtD
Doxepin—Palpitations—Epirubicin—peripheral nervous system neoplasm	8.86e-05	0.000284	CcSEcCtD
Doxepin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	8.81e-05	0.000282	CcSEcCtD
Doxepin—Cough—Epirubicin—peripheral nervous system neoplasm	8.75e-05	0.00028	CcSEcCtD
Doxepin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	8.74e-05	0.00028	CcSEcCtD
Doxepin—Convulsion—Epirubicin—peripheral nervous system neoplasm	8.69e-05	0.000278	CcSEcCtD
Doxepin—Nausea—Etoposide—peripheral nervous system neoplasm	8.67e-05	0.000278	CcSEcCtD
Doxepin—Hypertension—Epirubicin—peripheral nervous system neoplasm	8.66e-05	0.000277	CcSEcCtD
Doxepin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	8.61e-05	0.000276	CcSEcCtD
Doxepin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	8.58e-05	0.000275	CcSEcCtD
Doxepin—Chest pain—Epirubicin—peripheral nervous system neoplasm	8.54e-05	0.000273	CcSEcCtD
Doxepin—Myalgia—Epirubicin—peripheral nervous system neoplasm	8.54e-05	0.000273	CcSEcCtD
Doxepin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	8.54e-05	0.000273	CcSEcCtD
Doxepin—Agitation—Doxorubicin—peripheral nervous system neoplasm	8.53e-05	0.000273	CcSEcCtD
Doxepin—Anxiety—Epirubicin—peripheral nervous system neoplasm	8.51e-05	0.000272	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	8.48e-05	0.000272	CcSEcCtD
Doxepin—Discomfort—Epirubicin—peripheral nervous system neoplasm	8.43e-05	0.00027	CcSEcCtD
Doxepin—Malaise—Doxorubicin—peripheral nervous system neoplasm	8.37e-05	0.000268	CcSEcCtD
Doxepin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	8.35e-05	0.000267	CcSEcCtD
Doxepin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	8.34e-05	0.000267	CcSEcCtD
Doxepin—Syncope—Doxorubicin—peripheral nervous system neoplasm	8.32e-05	0.000266	CcSEcCtD
Doxepin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	8.3e-05	0.000266	CcSEcCtD
Doxepin—Confusional state—Epirubicin—peripheral nervous system neoplasm	8.25e-05	0.000264	CcSEcCtD
Doxepin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	8.2e-05	0.000263	CcSEcCtD
Doxepin—Oedema—Epirubicin—peripheral nervous system neoplasm	8.18e-05	0.000262	CcSEcCtD
Doxepin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	8.15e-05	0.000261	CcSEcCtD
Doxepin—ABCB1—cerebellum—peripheral nervous system neoplasm	8.15e-05	0.00302	CbGeAlD
Doxepin—Infection—Epirubicin—peripheral nervous system neoplasm	8.13e-05	0.00026	CcSEcCtD
Doxepin—Cough—Doxorubicin—peripheral nervous system neoplasm	8.1e-05	0.000259	CcSEcCtD
Doxepin—Shock—Epirubicin—peripheral nervous system neoplasm	8.05e-05	0.000258	CcSEcCtD
Doxepin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	8.04e-05	0.000257	CcSEcCtD
Doxepin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	8.03e-05	0.000257	CcSEcCtD
Doxepin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	8.01e-05	0.000257	CcSEcCtD
Doxepin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	8.01e-05	0.000257	CcSEcCtD
Doxepin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	7.99e-05	0.000256	CcSEcCtD
Doxepin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	7.95e-05	0.000255	CcSEcCtD
Doxepin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	7.91e-05	0.000253	CcSEcCtD
Doxepin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	7.9e-05	0.000253	CcSEcCtD
Doxepin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	7.9e-05	0.000253	CcSEcCtD
Doxepin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	7.9e-05	0.000253	CcSEcCtD
Doxepin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	7.87e-05	0.000252	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	7.84e-05	0.000251	CcSEcCtD
Doxepin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	7.8e-05	0.00025	CcSEcCtD
Doxepin—Anorexia—Epirubicin—peripheral nervous system neoplasm	7.8e-05	0.00025	CcSEcCtD
Doxepin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	7.73e-05	0.000247	CcSEcCtD
Doxepin—Hypotension—Epirubicin—peripheral nervous system neoplasm	7.65e-05	0.000245	CcSEcCtD
Doxepin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	7.63e-05	0.000245	CcSEcCtD
Doxepin—Oedema—Doxorubicin—peripheral nervous system neoplasm	7.57e-05	0.000242	CcSEcCtD
Doxepin—Infection—Doxorubicin—peripheral nervous system neoplasm	7.52e-05	0.000241	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	7.46e-05	0.000239	CcSEcCtD
Doxepin—Shock—Doxorubicin—peripheral nervous system neoplasm	7.45e-05	0.000239	CcSEcCtD
Doxepin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	7.43e-05	0.000238	CcSEcCtD
Doxepin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	7.41e-05	0.000237	CcSEcCtD
Doxepin—Insomnia—Epirubicin—peripheral nervous system neoplasm	7.4e-05	0.000237	CcSEcCtD
Doxepin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	7.39e-05	0.000237	CcSEcCtD
Doxepin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	7.35e-05	0.000236	CcSEcCtD
Doxepin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	7.35e-05	0.000235	CcSEcCtD
Doxepin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	7.32e-05	0.000234	CcSEcCtD
Doxepin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	7.3e-05	0.000234	CcSEcCtD
Doxepin—Somnolence—Epirubicin—peripheral nervous system neoplasm	7.28e-05	0.000233	CcSEcCtD
Doxepin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	7.22e-05	0.000231	CcSEcCtD
Doxepin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	7.2e-05	0.000231	CcSEcCtD
Doxepin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	7.11e-05	0.000228	CcSEcCtD
Doxepin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	7.08e-05	0.000227	CcSEcCtD
Doxepin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	7.07e-05	0.000226	CcSEcCtD
Doxepin—Fatigue—Epirubicin—peripheral nervous system neoplasm	7.06e-05	0.000226	CcSEcCtD
Doxepin—Pain—Epirubicin—peripheral nervous system neoplasm	7e-05	0.000224	CcSEcCtD
Doxepin—Constipation—Epirubicin—peripheral nervous system neoplasm	7e-05	0.000224	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	6.9e-05	0.000221	CcSEcCtD
Doxepin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	6.85e-05	0.000219	CcSEcCtD
Doxepin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	6.8e-05	0.000218	CcSEcCtD
Doxepin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	6.75e-05	0.000216	CcSEcCtD
Doxepin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	6.74e-05	0.000216	CcSEcCtD
Doxepin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	6.73e-05	0.000216	CcSEcCtD
Doxepin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	6.69e-05	0.000214	CcSEcCtD
Doxepin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	6.67e-05	0.000213	CcSEcCtD
Doxepin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	6.58e-05	0.000211	CcSEcCtD
Doxepin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	6.54e-05	0.000209	CcSEcCtD
Doxepin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	6.53e-05	0.000209	CcSEcCtD
Doxepin—Urticaria—Epirubicin—peripheral nervous system neoplasm	6.5e-05	0.000208	CcSEcCtD
Doxepin—Pain—Doxorubicin—peripheral nervous system neoplasm	6.48e-05	0.000207	CcSEcCtD
Doxepin—Constipation—Doxorubicin—peripheral nervous system neoplasm	6.48e-05	0.000207	CcSEcCtD
Doxepin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	6.47e-05	0.000207	CcSEcCtD
Doxepin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	6.47e-05	0.000207	CcSEcCtD
Doxepin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	6.24e-05	0.0002	CcSEcCtD
Doxepin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	6.19e-05	0.000198	CcSEcCtD
Doxepin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	6.03e-05	0.000193	CcSEcCtD
Doxepin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	6.02e-05	0.000193	CcSEcCtD
Doxepin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	5.99e-05	0.000192	CcSEcCtD
Doxepin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	5.99e-05	0.000192	CcSEcCtD
Doxepin—Asthenia—Epirubicin—peripheral nervous system neoplasm	5.87e-05	0.000188	CcSEcCtD
Doxepin—Pruritus—Epirubicin—peripheral nervous system neoplasm	5.79e-05	0.000185	CcSEcCtD
Doxepin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	5.6e-05	0.000179	CcSEcCtD
Doxepin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	5.58e-05	0.000179	CcSEcCtD
Doxepin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	5.43e-05	0.000174	CcSEcCtD
Doxepin—Dizziness—Epirubicin—peripheral nervous system neoplasm	5.41e-05	0.000173	CcSEcCtD
Doxepin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	5.36e-05	0.000172	CcSEcCtD
Doxepin—Vomiting—Epirubicin—peripheral nervous system neoplasm	5.2e-05	0.000167	CcSEcCtD
Doxepin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	5.18e-05	0.000166	CcSEcCtD
Doxepin—Rash—Epirubicin—peripheral nervous system neoplasm	5.16e-05	0.000165	CcSEcCtD
Doxepin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	5.16e-05	0.000165	CcSEcCtD
Doxepin—Headache—Epirubicin—peripheral nervous system neoplasm	5.13e-05	0.000164	CcSEcCtD
Doxepin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	5.01e-05	0.00016	CcSEcCtD
Doxepin—Nausea—Epirubicin—peripheral nervous system neoplasm	4.86e-05	0.000156	CcSEcCtD
Doxepin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	4.81e-05	0.000154	CcSEcCtD
Doxepin—Rash—Doxorubicin—peripheral nervous system neoplasm	4.77e-05	0.000153	CcSEcCtD
Doxepin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	4.77e-05	0.000153	CcSEcCtD
Doxepin—Headache—Doxorubicin—peripheral nervous system neoplasm	4.74e-05	0.000152	CcSEcCtD
Doxepin—Nausea—Doxorubicin—peripheral nervous system neoplasm	4.5e-05	0.000144	CcSEcCtD
Doxepin—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.09e-05	0.000149	CbGpPWpGaD
Doxepin—ADRA2C—Hemostasis—AKT1—peripheral nervous system neoplasm	1.07e-05	0.000146	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.06e-05	0.000144	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.05e-05	0.000143	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	1.04e-05	0.000142	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	1.03e-05	0.000141	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.03e-05	0.000141	CbGpPWpGaD
Doxepin—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	1.03e-05	0.000141	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.02e-05	0.00014	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.02e-05	0.000139	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.01e-05	0.000138	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.98e-06	0.000137	CbGpPWpGaD
Doxepin—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	9.82e-06	0.000135	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.81e-06	0.000134	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.75e-06	0.000134	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.7e-06	0.000133	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.69e-06	0.000133	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.63e-06	0.000132	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.63e-06	0.000132	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.58e-06	0.000131	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.5e-06	0.00013	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.49e-06	0.00013	CbGpPWpGaD
Doxepin—HTR6—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.42e-06	0.000129	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.39e-06	0.000129	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	9.37e-06	0.000128	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.34e-06	0.000128	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.34e-06	0.000128	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.32e-06	0.000128	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.29e-06	0.000127	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	9.23e-06	0.000126	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.17e-06	0.000126	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.14e-06	0.000125	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	9.06e-06	0.000124	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	9.01e-06	0.000123	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.94e-06	0.000122	CbGpPWpGaD
Doxepin—CHRM4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.89e-06	0.000122	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.85e-06	0.000121	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	8.81e-06	0.000121	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.81e-06	0.000121	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.75e-06	0.00012	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.74e-06	0.00012	CbGpPWpGaD
Doxepin—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	8.67e-06	0.000119	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.61e-06	0.000118	CbGpPWpGaD
Doxepin—HTR2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.6e-06	0.000118	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	8.56e-06	0.000117	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.56e-06	0.000117	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.52e-06	0.000117	CbGpPWpGaD
Doxepin—CHRM5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.51e-06	0.000117	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.5e-06	0.000116	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	8.49e-06	0.000116	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.47e-06	0.000116	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.46e-06	0.000116	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.45e-06	0.000116	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.43e-06	0.000115	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.43e-06	0.000115	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	8.42e-06	0.000115	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.4e-06	0.000115	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	8.33e-06	0.000114	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.32e-06	0.000114	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.32e-06	0.000114	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.3e-06	0.000114	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.29e-06	0.000114	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.28e-06	0.000113	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	8.26e-06	0.000113	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.25e-06	0.000113	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.23e-06	0.000113	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.17e-06	0.000112	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.15e-06	0.000112	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.07e-06	0.000111	CbGpPWpGaD
Doxepin—ADRA1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8e-06	0.00011	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.93e-06	0.000109	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.89e-06	0.000108	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.82e-06	0.000107	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.81e-06	0.000107	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.8e-06	0.000107	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.73e-06	0.000106	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.71e-06	0.000106	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.61e-06	0.000104	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.57e-06	0.000104	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.57e-06	0.000104	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.46e-06	0.000102	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.43e-06	0.000102	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.38e-06	0.000101	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.37e-06	0.000101	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.29e-06	9.98e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.27e-06	9.95e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.25e-06	9.93e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	7.23e-06	9.9e-05	CbGpPWpGaD
Doxepin—ADRA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.23e-06	9.89e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	7.19e-06	9.85e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.17e-06	9.82e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.16e-06	9.8e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.14e-06	9.78e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.14e-06	9.77e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.07e-06	9.68e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	7.06e-06	9.66e-05	CbGpPWpGaD
Doxepin—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.97e-06	9.55e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.94e-06	9.5e-05	CbGpPWpGaD
Doxepin—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.94e-06	9.5e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.91e-06	9.46e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.9e-06	9.45e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.88e-06	9.41e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.87e-06	9.41e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.83e-06	9.35e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	6.8e-06	9.31e-05	CbGpPWpGaD
Doxepin—ADRA2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.75e-06	9.24e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.69e-06	9.16e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.68e-06	9.15e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.65e-06	9.11e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.65e-06	9.1e-05	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.64e-06	9.09e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.59e-06	9.02e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.58e-06	9.02e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.58e-06	9.01e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.58e-06	9.01e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.56e-06	8.99e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.56e-06	8.98e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.54e-06	8.96e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.52e-06	8.93e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.46e-06	8.84e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.44e-06	8.82e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.33e-06	8.67e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.3e-06	8.63e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.3e-06	8.62e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.2e-06	8.49e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.19e-06	8.48e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.18e-06	8.47e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.16e-06	8.44e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.14e-06	8.41e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.13e-06	8.39e-05	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.12e-06	8.38e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.08e-06	8.33e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.07e-06	8.31e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.07e-06	8.31e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.03e-06	8.26e-05	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.03e-06	8.25e-05	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.01e-06	8.23e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6e-06	8.22e-05	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.99e-06	8.21e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.99e-06	8.2e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.98e-06	8.19e-05	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.97e-06	8.18e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.97e-06	8.17e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.96e-06	8.16e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.94e-06	8.13e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.92e-06	8.1e-05	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.92e-06	8.1e-05	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.9e-06	8.08e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.86e-06	8.03e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.85e-06	8e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.79e-06	7.93e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.76e-06	7.89e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.72e-06	7.84e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.65e-06	7.73e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.64e-06	7.72e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.6e-06	7.67e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.59e-06	7.65e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.56e-06	7.61e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	5.55e-06	7.6e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.52e-06	7.55e-05	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.48e-06	7.51e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.47e-06	7.49e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.46e-06	7.48e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.46e-06	7.48e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	5.45e-06	7.46e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.44e-06	7.45e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.43e-06	7.44e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.43e-06	7.43e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.41e-06	7.4e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.4e-06	7.39e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.4e-06	7.39e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.37e-06	7.36e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.37e-06	7.35e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.36e-06	7.34e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.23e-06	7.15e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.22e-06	7.15e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.17e-06	7.08e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.14e-06	7.04e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.09e-06	6.96e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.08e-06	6.96e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.05e-06	6.92e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5e-06	6.85e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.99e-06	6.84e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.98e-06	6.82e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.98e-06	6.81e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.96e-06	6.79e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.91e-06	6.73e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.9e-06	6.71e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.86e-06	6.66e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.77e-06	6.53e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.74e-06	6.49e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.66e-06	6.38e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.65e-06	6.37e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.64e-06	6.35e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.62e-06	6.33e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.61e-06	6.32e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.59e-06	6.28e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.58e-06	6.27e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.57e-06	6.25e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.56e-06	6.25e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.55e-06	6.23e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.43e-06	6.07e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.41e-06	6.04e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.39e-06	6.01e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—AKT1—peripheral nervous system neoplasm	4.33e-06	5.93e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.29e-06	5.88e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.29e-06	5.87e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.24e-06	5.81e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.24e-06	5.8e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.22e-06	5.78e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.22e-06	5.77e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.1e-06	5.61e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.04e-06	5.53e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.89e-06	5.33e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.88e-06	5.31e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—AKT1—peripheral nervous system neoplasm	3.83e-06	5.25e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.83e-06	5.24e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.82e-06	5.23e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.81e-06	5.21e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.8e-06	5.2e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.76e-06	5.15e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.75e-06	5.13e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.74e-06	5.12e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.72e-06	5.1e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.72e-06	5.09e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.66e-06	5.01e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.65e-06	5e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.64e-06	4.99e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.63e-06	4.97e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.62e-06	4.96e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.59e-06	4.92e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.58e-06	4.91e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.56e-06	4.88e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	3.52e-06	4.82e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.48e-06	4.77e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.33e-06	4.56e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.29e-06	4.5e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.23e-06	4.43e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.23e-06	4.42e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.22e-06	4.4e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.2e-06	4.39e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.17e-06	4.35e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.17e-06	4.33e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.94e-06	4.03e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	2.49e-06	3.41e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	2.43e-06	3.33e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	2.29e-06	3.14e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	2.27e-06	3.11e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.94e-06	2.66e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.5e-06	2.05e-05	CbGpPWpGaD
